Navigation überspringen
Universitätsbibliothek Heidelberg
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Nürnberg, Hannah [VerfasserIn]   i
 Khatamzas, Elham [VerfasserIn]   i
 Denkinger, Claudia M. [VerfasserIn]   i
 Krause, Tabea [VerfasserIn]   i
 Oetken, Lars [VerfasserIn]   i
 Rauer, Sophie [VerfasserIn]   i
 Rapp, Amelie [VerfasserIn]   i
 Hoppe-Tichy, Torsten [VerfasserIn]   i
 Morath, Benedict [VerfasserIn]   i
Titel:Effectiveness, barriers and facilitating factors of strategies for active delabelling of patients with penicillin allergy labels
Titelzusatz:a systematic review protocol
Verf.angabe:Hannah Nürnberg, Elham Khatamzas, Claudia Denkinger, Tabea Krause, Lars Oetken, Sophie Rauer, Amelie Rapp, Torsten Hoppe-Tichy, Benedict Morath
Jahr:2024
Umfang:5 S.
Fussnoten:Gesehen am 03.06.2024
Titel Quelle:Enthalten in: BMJ open
Ort Quelle:London : BMJ Publishing Group, 2011
Jahr Quelle:2024
Band/Heft Quelle:14(2024), 2, Artikel-ID e077927, Seite 1-5
ISSN Quelle:2044-6055
Abstract:Introduction Up to 15% of adult patients in the clinical setting report to be allergic to penicillin. However, in most cases, penicillin allergy is not confirmed. Due to the negative aspects associated with erroneous penicillin allergy, the implementation of active delabelling processes for penicillin allergy is an important part of antibiotic stewardship programmes. Depending on the clinical setting, different factors need to be considered during implementation. This review examines the effectiveness of different delabelling interventions and summarises components and structures that facilitate, support or constrain structured penicillin allergy delabelling. - Methods and analysis This review will adhere to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. The databases MEDLINE (via PubMed), EMBASE and Cochrane Library were searched for studies reporting on any intervention to identify, assess or rule out uncertain penicillin allergy. To improve completeness, two further databases are also searched for grey literature. Study design, intervention type, professional groups involved, effectiveness, limitations, barriers, facilitating factors, clinical setting and associated regulatory factors will be extracted and analysed. In addition, exclusion criteria for participation in the delabelling intervention and criteria for not delabelling penicillin allergy will be summarised. In case of failed protocols, these are highlighted and quantitatively analysed if possible. Two independent reviewers will perform the screening process and data extraction. Discordant decisions will be resolved through review by a third reviewer. Bias assessment of the individual studies will be performed using the Newcastle Ottawa Scale. - Ethics and dissemination Because individual patient-related data are not analysed, an ethical approval is not required. The review will be published in a peer-reviewed scientific journal.
DOI:doi:10.1136/bmjopen-2023-077927
URL:kostenfrei: Volltext: https://doi.org/10.1136/bmjopen-2023-077927
 kostenfrei: Volltext: https://bmjopen.bmj.com/content/14/2/e077927
 DOI: https://doi.org/10.1136/bmjopen-2023-077927
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:CLINICAL PHARMACOLOGY
 INFECTIOUS DISEASES
 INTERNAL MEDICINE
K10plus-PPN:1890512842
Verknüpfungen:→ Zeitschrift
 
 
Lokale URL UB: Zum Volltext

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69219531   QR-Code
zum Seitenanfang